Therapy Areas: AIDS & HIV
8 November 2018 - Bridge Therapeutics, a late development-stage specialty pharmaceutical company, has added Steven Passik PhD to its Scientific Advisory Board, it was reported yesterday.Dr Passik PhD,...
8 November 2018 - United Kingdom-based AstraZeneca has agreed to offload its rights to asthma drug Alvesco (ciclesonide) and nasal sprays Omnaris and Zetonna (ciclesonide) to Covis Pharma, a Switzerla...
2 November 2018 - United Kingdom-based ViiV Healthcare has revealed positive results for its phase three BRIGHTE study of investigational Fostemsavir at 48 weeks in heavily treatment-experienced patie...
1 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has released 96-week results from a Phase 3, randomized, double-blinded study (Study 1490) evaluating the sa...
1 November 2018 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) The Janssen Pharmaceutical Companies business has unveiled 96-week results from the pivotal Phase 3 AMBER study o...
30 October 2018 - It was reported yesterday that NanoViricides Inc (NYSE Amer: NNVC), a leader in developing novel nanomedicines to treat viral diseases, has named James Sapirstein as the Independent ...